No Data
No Data
No Data
Neusoft Medical Systems Showcases AI-powered Medical Imaging Solutions at RSNA 2024
Stereotaxis' GenesisX Robotic System to Be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems
Positron Corporation Enters New Manufacturing & Components Supplier Cooperative With Neusoft Medical Systems Subsidiary for New PET-CT Device
Neusoft Medical submits to Hong Kong Stock Exchange: Profit rose more than 220% year-on-year during the year, leading the domestic CT market
Hong Kong's Wande News Agency reports that the Hong Kong Stock Exchange recently revealed that Neusoft Medical submitted an application for listing on the main board of the Hong Kong Stock Exchange, with CICC and Goldman Sachs as co-sponsors. (Image source: Neusoft Medical Prospectus) According to the prospectus, Neusoft Healthcare was founded in 1998 and is a leading provider of medical imaging solutions and services in China. According to Frost & Sullivan's data, based on the total number of systems installed in 2021, the company is the largest domestic computed tomography (CT) system manufacturer and the fourth largest CT system manufacturer in China, with a market share of 11.5%. Based on sales in 2021, Neusoft Medical is also the largest C in China
Weekly IPO | The “First Gene-Edited Stock” Officially Listed on the Hong Kong Stock Exchange, and Jingdang Health's IPO is underway
New energy vehicle company Zero Run Technology and Wanwuyun, a subsidiary of Vanke, have passed the Hong Kong Stock Exchange listing hearing. Digital healthcare home service leader Jingdang Health Prospecting ended on September 6.
Neusoft Medical submitted its third listing on the main board of the Hong Kong Stock Exchange. The company is the largest domestic computed tomography system manufacturer in China
Neusoft Medical was founded in 1998 and is a leading provider of medical imaging solutions and services in China.
Unlock the Full List